Healthcare Facilities Trust Sephure

We trialed Sephure in our facility and got a lot of positive feedback from our nurses.  Not only is this device more dignified for the patient, it’s also more dignified for the nurse who has to give the suppository.  This applicator ensures the suppository end up in the right place, which means nurses don’t have to worry about them moving out of place before they can be effective.  Great product!

Kayte M., RN, WNC

We offer free demonstrations, training for nurses and Sephure suppository applicators for testing in your facility. This trial is FREE, just sign up below and we will contact you to schedule a time for training.

Health Care Facility Trial

Facility request for free Sephure applicator training

Why Nurses use Sephure

Nurses prefer Sephure applicators for administering suppositories to finger administration for the following reasons:


Why Healthcare Facilities Use Sephure

Nursing facilities have conducted value analysis of Sephure applicators and believe it to be a consistent standard of care that  mitigates the risks of infection transfer and workplace injury.

The Number 1 workplace injury in hospital and nursing facilities is associated with  moving a patient. With Sephure applicators, the suppository is properly placed, reducing the number of re-administrations and potential clean up from a misplaced suppository.

C-difficile is the leading healthcare facility acquired infection.  C-diff spores are transferred to patients mainly from the hands of nurses who have touched a contaminated surface or device.  Sephure applicators, limit the nurse/patient contact.

According to an insurance risk assessor for LTC facilities in New England, adoption of Sephure mitigates risk of cross infection (C-difficile is the leading healthcare facility acquired infection) and workplace injury.

  • The savings of preventing one workplace injury is equal to a SIX year supply of Sephure. Avg cost for each workplace injury =$15,860.
  • The savings of preventing one C.-difficile infection is equal to a NINE year supply of Sephure. Avg cost for each C.-diff infection =$23,534.